69 research outputs found

    Schema Languages & Internationalization Issues: A survey

    Get PDF
    Many XML-related activities (e.g. the creation of a new schema) already address issues with different languages, scripts, and cultures. Nevertheless, a need exists for additional mechanisms and guidelines for more effective internationalization (i18n) and localization (l10n) in XML-related contents and processes. The W3C Internationalization Tag Set Working Group (W3C ITS WG) addresses this need and works on data categories, representation mechanisms and guidelines related to i18n and l10n support in the XML realm. This paper describes initial findings from the (W3C ITS WG). Furthermore, the paper discusses how these findings relate to specific schema languages, and complementary technologies like namespace sectioning, schema annotation and the description of processing chains. The paper exemplifies why certain requirements only can be met by a combination of technologies, and discusses these technologies

    Untersuchung der Wirksamkeit einer Lernhandlung in einem Blended-Learning-Arrangement in der universitären Ausbildung

    Get PDF
    1 Unterstützung der Lernhandlung zur Förderung der beruflichen Handlungskompetenz in der universitären Ausbildung Ein Großteil der Hochschulabsolventen ist nach Beendigung des Studiums in Unternehmen tätig. Diese fordern von den Absolventen neben fachlichen Kompetenzen vor allem Methoden- und Sozialkompetenz. Fachspezifische Kompetenzen bilden gemeinsam mit Methoden- und Sozialkompetenzen die Grundlage für die Berufsfähigkeit im Sinne beruflicher Handlungskompetenz der Absolventen. In einer Studie des Institutes der deutschen Wirtschaft Köln aus dem Jahre 2010 gaben rund zwei Drittel der befagten Unternehmen an, dass sie es im Bereich der Fach- und Methodenkompetenzen für sehr wichtig halten, dass die Absolventen in der Lage sind, sich in neue Fachgebiete selbstständig einzuarbeiten und vorhandenes Wissen auf neue Probleme anwenden zu können. Das Vorhandensein speziellen Fachwissens spielt hingegen für die Arbeitgeber eher eine untergeordnete Rolle (Konegen- Grenier, Placke & Stangl, 2011, S. 86 ff.). In einer repräsentativen Befragung unter Studierenden im Jahre 2010 gaben ca. 25 Prozent der Befragten an bisher nicht oder eher nicht gefördert worden zu sein (Heine, Woisch & Ortenburger, 2011, S. 31). Einen entscheidenden Einfluss auf die Kompetenzförderung hat die Lernhandlung. In Anlehnung an Richter (2001, S. 46) werden Lernhandlungen in diesem Aufsatz als zielgerichtete Handlungen angesehen, welche sich auf die bewusste und reflektierte Weiterentwicklung der eigenen Handlungskompetenz (Berufsbefähigung) beziehen. Die Lernhandlung zeichnet sich durch die Merkmale des handlungsorientierten Lernens aus. Handlungsorientiertes Lernen ist gekennzeichnet durch Selbststeuerung, Wahl von Handlungsalternativen und Vollständigkeit, im Sinne von Zielbildung, Planung, Durchführung und Kontrolle. Es ist auf Lernzuwachs und Wissenserwerb ausgerichtet und erfolgt bewusst und reflexiv (Richter, 2001, S. 47). [...

    Reassessing the need for carbon dioxide removal: moral implications of alternative climate target pathways

    Get PDF
    Non-technical summary Scenarios compatible with the Paris agreement's temperature goal of 1.5 °C involve carbon dioxide removal measures – measures that actively remove CO2 from the atmosphere – on a massive scale. Such large-scale implementations raise significant ethical problems. Van Vuuren et al. (2018), as well as the current IPCC scenarios, show that reduction in energy and or food demand could reduce the need for such activities. There is some reluctance to discuss such societal changes. However, we argue that policy measures enabling societal changes are not necessarily ethically problematic. Therefore, they should be discussed alongside techno-optimistic approaches in any kind of discussions about how to respond to climate change. Technical summary The 1.5 °C goal has given impetus to carbon dioxide removal (CDR) measures, such as bioenergy combined with carbon capture and storage, or afforestation. However, land-based CDR options compete with food production and biodiversity protection. Van Vuuren et al. (2018) looked at alternative pathways including lifestyle changes, low-population projections, or non-CO2 greenhouse gas mitigation, to reach the 1.5 °C temperature objective. Underlined by the recently published IPCC AR6 WGIII report, they show that demand-side management measures are likely to reduce the need for CDR. Yet, policy measures entailed in these scenarios could be associated with ethical problems themselves. In this paper, we therefore investigate ethical implications of four alternative pathways as proposed by Van Vuuren et al. (2018). We find that emission reduction options such as lifestyle changes and reducing population, which are typically perceived as ethically problematic, might be less so on further inspection. In contrast, options associated with less societal transformation and more techno-optimistic approaches turn out to be in need of further scrutiny. The vast majority of emission reduction options considered are not intrinsically ethically problematic; rather everything rests on the precise implementation. Explicitly addressing ethical considerations when developing, advancing, and using integrated assessment scenarios could reignite debates about previously overlooked topics and thereby support necessary societal discourse. Social media summary Policy measures enabling societal changes are not necessarily as ethically problematic as commonly presumed and reduce the need for large-scale CDR

    European language equality

    Get PDF
    This deep dive on data, knowledge graphs (KGs) and language resources (LRs) is the final of the four technology deep dives, as data as well as related models are the basis for technologies and solutions in the area of Language Technology (LT) for European digital language equality (DLE). This chapter focuses on the data and LRs required to achieve full DLE in Europe by 2030. The main components identified – data, KGs, LRs – are explained, and used to analyse the state-of-the-art as well as identify gaps. All of these components need to be tackled in the future, for the widest range of languages possible, from official EU languages to dialects to non- EU languages used in Europe. For all these languages, efficient data collection and sustainable data provision to be facilitated with fair conditions and costs. Specific technologies, methodologies and tools have been identified to enable the implementation of the vision of DLE by 2030. In addition, data-related business models and data-governance models are discussed, as they are considered a prerequisite for a working data economy that stimulates a vibrant LT landscape that can bring about European DLE.peer-reviewe

    Deep dive machine translation

    Get PDF
    Machine Translation (MT) is one of the oldest language technologies having been researched for more than 70 years. However, it is only during the last decade that it has been widely accepted by the general public, to the point where in many cases it has become an indispensable tool for the global community, supporting communication between nations and lowering language barriers. Still, there remain major gaps in the technology that need addressing before it can be successfully applied in under-resourced settings, can understand context and use world knowledge. This chapter provides an overview of the current state-of-the-art in the field of MT, offers technical and scientific forecasting for 2030, and provides recommendations for the advancement of MT as a critical technology if the goal of digital language equality in Europe is to be achieved

    Glycinergic interneurons are functionally integrated into the inspiratory network of mouse medullary slices

    Get PDF
    Neuronal activity in the respiratory network is functionally dependent on inhibitory synaptic transmission. Using two-photon excitation microscopy, we analyzed the integration of glycinergic neurons in the isolated inspiratory pre-Bötzinger complex-driven network of the rhythmic slice preparation. Inspiratory (96%) and ‘tonic’ expiratory neurons (4%) were identified via an increase or decrease, respectively, of the cytosolic free calcium concentration during the inspiratory-related respiratory burst. Furthermore, in BAC-transgenic mice expressing EGFP under the control of the GlyT2-promoter, 50% of calcium-imaged inspiratory neurons were glycinergic. Inspiratory bursting of glycinergic neurons in the slice was confirmed by whole-cell recording. We also found glycinergic neurons that receive phasic inhibition from other glycinergic neurons. Our calcium imaging data show that glycinergic neurons comprise a large population of inspiratory neurons in the pre-Bötzinger complex-driven network of the rhythmic slice preparation

    Antimicrobial resistance among migrants in Europe: a systematic review and meta-analysis

    Get PDF
    BACKGROUND: Rates of antimicrobial resistance (AMR) are rising globally and there is concern that increased migration is contributing to the burden of antibiotic resistance in Europe. However, the effect of migration on the burden of AMR in Europe has not yet been comprehensively examined. Therefore, we did a systematic review and meta-analysis to identify and synthesise data for AMR carriage or infection in migrants to Europe to examine differences in patterns of AMR across migrant groups and in different settings. METHODS: For this systematic review and meta-analysis, we searched MEDLINE, Embase, PubMed, and Scopus with no language restrictions from Jan 1, 2000, to Jan 18, 2017, for primary data from observational studies reporting antibacterial resistance in common bacterial pathogens among migrants to 21 European Union-15 and European Economic Area countries. To be eligible for inclusion, studies had to report data on carriage or infection with laboratory-confirmed antibiotic-resistant organisms in migrant populations. We extracted data from eligible studies and assessed quality using piloted, standardised forms. We did not examine drug resistance in tuberculosis and excluded articles solely reporting on this parameter. We also excluded articles in which migrant status was determined by ethnicity, country of birth of participants' parents, or was not defined, and articles in which data were not disaggregated by migrant status. Outcomes were carriage of or infection with antibiotic-resistant organisms. We used random-effects models to calculate the pooled prevalence of each outcome. The study protocol is registered with PROSPERO, number CRD42016043681. FINDINGS: We identified 2274 articles, of which 23 observational studies reporting on antibiotic resistance in 2319 migrants were included. The pooled prevalence of any AMR carriage or AMR infection in migrants was 25·4% (95% CI 19·1-31·8; I2 =98%), including meticillin-resistant Staphylococcus aureus (7·8%, 4·8-10·7; I2 =92%) and antibiotic-resistant Gram-negative bacteria (27·2%, 17·6-36·8; I2 =94%). The pooled prevalence of any AMR carriage or infection was higher in refugees and asylum seekers (33·0%, 18·3-47·6; I2 =98%) than in other migrant groups (6·6%, 1·8-11·3; I2 =92%). The pooled prevalence of antibiotic-resistant organisms was slightly higher in high-migrant community settings (33·1%, 11·1-55·1; I2 =96%) than in migrants in hospitals (24·3%, 16·1-32·6; I2 =98%). We did not find evidence of high rates of transmission of AMR from migrant to host populations. INTERPRETATION: Migrants are exposed to conditions favouring the emergence of drug resistance during transit and in host countries in Europe. Increased antibiotic resistance among refugees and asylum seekers and in high-migrant community settings (such as refugee camps and detention facilities) highlights the need for improved living conditions, access to health care, and initiatives to facilitate detection of and appropriate high-quality treatment for antibiotic-resistant infections during transit and in host countries. Protocols for the prevention and control of infection and for antibiotic surveillance need to be integrated in all aspects of health care, which should be accessible for all migrant groups, and should target determinants of AMR before, during, and after migration. FUNDING: UK National Institute for Health Research Imperial Biomedical Research Centre, Imperial College Healthcare Charity, the Wellcome Trust, and UK National Institute for Health Research Health Protection Research Unit in Healthcare-associated Infections and Antimictobial Resistance at Imperial College London

    Calpeptin is a potent cathepsin inhibitor and drug candidate for SARS-CoV-2 infections

    Get PDF
    Several drug screening campaigns identified Calpeptin as a drug candidate against SARS-CoV-2. Initially reported to target the viral main protease (Mpro), its moderate activity in Mpro inhibition assays hints at a second target. Indeed, we show that Calpeptin is an extremely potent cysteine cathepsin inhibitor, a finding additionally supported by X-ray crystallography. Cell infection assays proved Calpeptin’s efficacy against SARS-CoV-2. Treatment of SARS-CoV-2-infected Golden Syrian hamsters with sulfonated Calpeptin at a dose of 1 mg/kg body weight reduces the viral load in the trachea. Despite a higher risk of side effects, an intrinsic advantage in targeting host proteins is their mutational stability in contrast to highly mutable viral targets. Here we show that the inhibition of cathepsins, a protein family of the host organism, by calpeptin is a promising approach for the treatment of SARS-CoV-2 and potentially other viral infections

    X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 main protease

    Get PDF
    The coronavirus disease (COVID-19) caused by SARS-CoV-2 is creating tremendous human suffering. To date, no effective drug is available to directly treat the disease. In a search for a drug against COVID-19, we have performed a high-throughput X-ray crystallographic screen of two repurposing drug libraries against the SARS-CoV-2 main protease (M^(pro)), which is essential for viral replication. In contrast to commonly applied X-ray fragment screening experiments with molecules of low complexity, our screen tested already approved drugs and drugs in clinical trials. From the three-dimensional protein structures, we identified 37 compounds that bind to M^(pro). In subsequent cell-based viral reduction assays, one peptidomimetic and six non-peptidic compounds showed antiviral activity at non-toxic concentrations. We identified two allosteric binding sites representing attractive targets for drug development against SARS-CoV-2

    Massive X-ray screening reveals two allosteric drug binding sites of SARS-CoV-2 main protease

    Get PDF
    The coronavirus disease (COVID-19) caused by SARS-CoV-2 is creating tremendous health problems and economical challenges for mankind. To date, no effective drug is available to directly treat the disease and prevent virus spreading. In a search for a drug against COVID-19, we have performed a massive X-ray crystallographic screen of repurposing drug libraries containing 5953 individual compounds against the SARS-CoV-2 main protease (Mpro), which is a potent drug target as it is essential for the virus replication. In contrast to commonly applied X-ray fragment screening experiments with molecules of low complexity, our screen tested already approved drugs and drugs in clinical trials. From the three-dimensional protein structures, we identified 37 compounds binding to Mpro. In subsequent cell-based viral reduction assays, one peptidomimetic and five non-peptidic compounds showed antiviral activity at non-toxic concentrations. Interestingly, two compounds bind outside the active site to the native dimer interface in close proximity to the S1 binding pocket. Another compound binds in a cleft between the catalytic and dimerization domain of Mpro. Neither binding site is related to the enzymatic active site and both represent attractive targets for drug development against SARS-CoV-2. This X-ray screening approach thus has the potential to help deliver an approved drug on an accelerated time-scale for this and future pandemics
    corecore